US › Healthcare

Voyager Therapeutics Inc (VYGR)

US · Healthcare · Biotechnology

$3.12+4.17%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$2.6M
Revenue YoY
-59.9%
Net profit
$-27.9M
Profit YoY
+9.9%
EPS
$-0.47
EPS estimate
$-0.53
Net margin
-1,077.4%

EPS came in at -0.47 against a street estimate of -0.53 — a beat of 11.3%.

Key statistics

Market cap
$181.3M
Forward P/E
8.4
P/B
1.05
Book value
$2.88
EPS (TTM)
$-1.98
52-week high
$5.55
52-week low
$2.94
50-day MA
$3.47
200-day MA
$3.93
Beta
1.31

Analyst view

Analysts rate Voyager Therapeutics Inc a strong buy (12 buy, 0 hold, 0 sell out of 12) with an average price target of $14.89.

Shareholding

Insiders
15.14%
Institutions
55.51%

Largest institutional holders

FundStake
BlackRock Inc9.22%
Armistice Capital, LLC5.79%
Millennium Management LLC5.67%
Vanguard Group Inc5.41%
Vestal Point Capital LP4.97%
Vanguard Capital Management, LLC3.78%
Opaleye Management Inc1.90%
Erste Asset Management GmbH1.81%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Voyager Therapeutics Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.